NCT06308146View on ClinicalTrials.gov

Effect of Bacillus Subtilis ATCC 122264 Supplementation on Gas Symptoms and Quality of Life in Participants With Functional Bloating

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 21, 2022

Primary Completion Date

October 11, 2022

Study Completion Date

October 11, 2022

Conditions
Functional Bloating
Interventions
DIETARY_SUPPLEMENT

Bacillus subtilis ATCC 122264

One capsule (5 billion CFU) per day for 8 weeks.

DIETARY_SUPPLEMENT

Placebo

One capsule per day for 8 weeks.

Trial Locations (1)

N1G 0B4

Apex Trials, Guelph

All Listed Sponsors
collaborator

Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

NETWORK

lead

Kerry Group P.L.C

INDUSTRY